RSSReview

A Cannabinoid Hypothesis of Schizophrenia: Pathways to Psychosis

A Cannabinoid Hypothesis of Schizophrenia: Pathways to Psychosis

| July 1, 2022

by Rachel Little, MA, and Dale D’Mello, MD Ms. Little is a science writer in Lansing, Michigan. Dr. D’Mello is Associate Professor Emeritus with the Department of Psychiatry at Michigan State University in East Lansing, Michigan. Funding: No funding was provided for this article. Disclosures: The authors have no conflicts of interest relevant to the […]

Continue Reading

Noah Syndrome: A Review Regarding Animal Hoarding with Squalor

Noah Syndrome: A Review Regarding Animal Hoarding with Squalor

| July 1, 2022

by Leonor Moreira Abreu, MD, MSc, and João Gama Marques, MD, MSc, PhD Dr. Moreira Abreu and Prof. Gama Marques are with Clínica Universitária de Psiquiatria e Psicologia Médica, Faculdade de Medicina, Universidade de Lisboa in Lisbon, Portugal. Prof. Gama Marques is with Consulta de Esquizofrenia Resistente, Hospital Júlio de Matos, Centro Hospitalar Psiquiátrico de […]

Continue Reading

Use of Repetitive Transcranial Magnetic Stimulation in Child Psychiatry

Use of Repetitive Transcranial Magnetic Stimulation in Child Psychiatry

| April 1, 2022

by Anca Maria Bejenaru, MD, and Narpinder Kaur Malhi, MD Drs. Bejenaru and Malhi are with the Department of Psychiatry and Behavioral Health, Christiana Care in Wilmington, Delaware. Funding: No funding was provided for this study. Disclosures: The authors have no conflicts of interest relevant to the content of this article. Innov Clin Neurosci. 2022;19(4–6):11–22. […]

Continue Reading

Comparative Analysis of Treatment Outcomes in Patients with Neuromyelitis Optica Spectrum Disorder Treated with Rituximab, Azathioprine, and Mycophenolate Mofetil: A Systematic Review and Meta-analysis

Comparative Analysis of Treatment Outcomes in Patients with Neuromyelitis Optica Spectrum Disorder Treated with Rituximab, Azathioprine, and Mycophenolate Mofetil: A Systematic Review and Meta-analysis

| April 1, 2022

by Christy Magdalena, MD, MRes; Audrey Clarissa, MD, MRes; and Nathania Sutandi, MD, MRes All authors are with Faculty of Medicine, Universitas Indonesia, Cipto Mangunkusumo National Referral Hospital in Jakarta, Indonesia. Funding: No funding was provided for this study. Disclosures: The authors have no conflicts of interest relevant to the article. Innov Clin Neurosci. 2022;19(4–6):51–64. Abstract […]

Continue Reading

Implementing Digital Technologies in Clinical Trials: Lessons Learned

Implementing Digital Technologies in Clinical Trials: Lessons Learned

| April 1, 2022

by Georgia Mitsi, PhD; Todd Grinnell, BA; Suzanne Giordano, PhD; Thomas Goodin, Phd; Shahin Sanjar, PhD; Elizabeth Marble, BS; and Andrei Pikalov, MD, PhD All authors are with Sunovion Pharmaceuticals Inc. in Marlborough, Massachusetts. Funding: The studies described herein and medical writing support were supported by funding from Sunovion Pharmaceuticals Inc.   Disclosures: All authors […]

Continue Reading

The Role of Transcranial Magnetic Stimulation as a Surrogate Marker of Disease Activity in Patients with Multiple Sclerosis: A Literature Review

The Role of Transcranial Magnetic Stimulation as a Surrogate Marker of Disease Activity in Patients with Multiple Sclerosis: A Literature Review

| January 1, 2022

by Muhannad M. Alsharidah, MBBS; Mohammad Uzair, BS; Sarah S. Alseneidi, MBBS; Afnan A. Alkharan, MBBS; Reem Fahd Bunyan, MBBS; and Shahid Bashir, PhD Drs. Alsharidah and Alseneidi are with the College of Medicine, King Saud University in Riyadh, Saudi Arabia. Mr. Uzair is with the Department of Biological Sciences, Faculty of Basic and Applied […]

Continue Reading

Making Sense of the Matrix: A Qualitative Assessment and Commentary on Connecting Psychiatric Symptom Scale Items to the Research Domain Criteria (RDoC)

Making Sense of the Matrix: A Qualitative Assessment and Commentary on Connecting Psychiatric Symptom Scale Items to the Research Domain Criteria (RDoC)

| January 1, 2022

by Leslie Citrome, MD, MPH; Anissa Abi-Dargham, MD; Robert M. Bilder, PhD; Ruth A. Duffy, PhD; Boadie W. Dunlop, MD; Philip D. Harvey, PhD; Diego A. Pizzagalli, PhD; Carol A. Tamminga, MD; Roger S. McIntyre, MD; and John M. Kane, MD Dr. Citrome is with New York Medical College in Valhalla, New York. Dr. Abi-Dargham is with […]

Continue Reading

Pimavanserin in the Treatment of Parkinson’s Disease Psychosis: Meta-analysis and Meta-regression of Randomized Clinical Trials

Pimavanserin in the Treatment of Parkinson’s Disease Psychosis: Meta-analysis and Meta-regression of Randomized Clinical Trials

| January 1, 2022

by Zeeshan Mansuri, MD, MPH; Abhishek Reddy, MD; Ramu Vadukapuram, MD; Chintan Trivedi, MD, MPH; and Amy Amara, MD, PhD  Dr. Mansuri is with the Department of Psychiatry, Boston Children’s Hospital/Harvard Medical School in Boston, Massachusetts. Dr. Reddy is with the Department of Psychiatry, Virginia Tech Carilion School of Medicine in Roanoke, Virginia. Dr. Vadukapuram is with […]

Continue Reading